J. Miceli - Concepedia

Author

J. Miceli

Pfizer (United States)

Also Known As

J J Miceli, J MICELI, J Miceli, J. J. Miceli, J. Miceli, J.J. Miceli, Jeff Miceli

Publications

574

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Pfizer (United Kingdom)

About

J. Miceli is an author at Pfizer (United States) specializing in toxicology, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	33
2	Biochemistry	2	2	33
3	Pharmacology	2	2	33
4	Metabolism	1	1	12
5	Clinical Pharmacology	1	1	12

J. Miceli

Publications

524

Citations

H-Index

Page 1

	Year	Citations
Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions Chandra Prakash, Amin Kamel, Donghui Cui, British Journal of Clinical Pharmacology	2000	123
The effect of carbamazepine on the steady‐state pharmacokinetics of ziprasidone in healthy volunteers J. Miceli, Richard Anziano, L. Robarge, British Journal of Clinical Pharmacology	2000	92
Single‐ and multiple‐dose pharmacokinetics of ziprasidone under non‐fasting conditions in healthy male volunteers J. Miceli, Keith D. Wilner, RA Hansen, British Journal of Clinical Pharmacology	2000	84
Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study Eduard Vieta, Tanya Ramey, David Keller, Journal of Psychopharmacology	2008	77
The effects of ketoconazole on ziprasidone pharmacokinetics —a placebo‐controlled crossover study in healthy volunteers J. Miceli, Michael K. Smith, L. Robarge, British Journal of Clinical Pharmacology	2000	73
An 8-Week, Randomized, Phase 2, Double-Blind, Sequential Parallel-Group Comparison Study of Two Dose Levels of the GABAA Positive Allosteric Modulator PF-06372865 Compared With Placebo as an Adjunctive Treatment in Outpatients With Inadequate Response to Standard of Care for Generalized Anxiety Disorder Arthur A. Simen, Mark Whitlock, Ruolun Qiu, Journal of Clinical Psychopharmacology	2018	24
Tissue distribution and elimination kinetics of poly-brominated biphenyls (PBB) from rat tissue J. Miceli, Bradley P. Marks Toxicology Letters BiochemistryMedicineRat TissuePoly-brominated BiphenylsToxicology	1981	21
Bioavailability Studies of Drugs with Nonlinear Pharmacokinetics: II. Absolute Bioavailability of Intravenous Phenytoin Prodrug at Therapeutic Phenytoin Serum Concentrations Determined by Double‐Stable Isotope Technique T. R. Browne, G. Szabó, Carol M. McEntegart, The Journal of Clinical Pharmacology	1993	18
Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers. Chandra Prakash, Donghui Cui, James G. Baxter, PubMed PsychopharmacologyPharmacotherapyCumulative ExcretionSulfate ConjugateExperimental Pharmacology	1998	12

Page 1